Phase III study of letrozole versus tamoxifen as first-line therapy of advanced breast cancer in postmenopausal women: analysis of survival and update of efficacy from the International Letrozole Breast Cancer Group (Q44459245)

From Wikidata
Jump to navigation Jump to search
scientific article published in June 2003
edit
Language Label Description Also known as
English
Phase III study of letrozole versus tamoxifen as first-line therapy of advanced breast cancer in postmenopausal women: analysis of survival and update of efficacy from the International Letrozole Breast Cancer Group
scientific article published in June 2003

    Statements

    Phase III study of letrozole versus tamoxifen as first-line therapy of advanced breast cancer in postmenopausal women: analysis of survival and update of efficacy from the International Letrozole Breast Cancer Group (English)
    Henning Mouridsen
    Mikhail Gershanovich
    Ramon Perez-Carrion
    Corrado Boni
    Alain Monnier
    Justus Apffelstaedt
    Robert Smith
    Harm P Sleeboom
    Fritz Jaenicke
    Magdolna Dank
    Dominique Becquart
    Poonamalle P Bapsy
    Eeva Salminen
    Ray Snyder
    Hilary Chaudri-Ross
    Raquel Lang
    Peter Wyld
    Ajay Bhatnagar
    2101-2109

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit